-
1
-
-
67650874081
-
Cancer statistics, 2009
-
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225-249
-
(2009)
CA Cancer J Clin
, vol.59
, pp. 225-249
-
-
Jemal, A.1
Siegel, R.2
Ward, E.3
Hao, Y.4
Xu, J.5
Thun, M.J.6
-
2
-
-
58949095678
-
Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans
-
El-Serag HB, Engels EA, Landgren O, et al. Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: a population-based study of U.S. veterans. Hepatology 2009;49: 116-123
-
(2009)
Hepatology
, vol.49
, pp. 116-123
-
-
El-Serag, H.B.1
Engels, E.A.2
Landgren, O.3
-
3
-
-
33745234796
-
Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971-200L
-
West J, Wood H, Logan RF, Quinn M, Aithal GP. Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971-200L BrJ Cancer 2006;4:1751-1758
-
(2006)
BrJ Cancer
, vol.4
, pp. 1751-1758
-
-
West, J.1
Wood, H.2
Logan, R.F.3
Quinn, M.4
Aithal, G.P.5
-
4
-
-
34047146961
-
Molecular pathology of biliary tract cancers
-
Fava G, Marzioni M, Benedetti A, et al. Molecular pathology of biliary tract cancers. Cancer Lett 2007;250:155-167
-
(2007)
Cancer Lett
, vol.250
, pp. 155-167
-
-
Fava, G.1
Marzioni, M.2
Benedetti, A.3
-
5
-
-
4544297463
-
Gallbladder cancer: Lessons from a rare tumour
-
Wistuba II, Gazdar AF. Gallbladder cancer: lessons from a rare tumour. Nat Rev Cancer 2004;4:695-706.
-
(2004)
Nat Rev Cancer
, vol.4
, pp. 695-706
-
-
Wistuba, I.I.1
Gazdar, A.F.2
-
6
-
-
46149087994
-
Survival after resection of ampullary carcinoma: A national populationbased study
-
O'Connell JB, Maggard MA, Manunga J Jr, et al. Survival after resection of ampullary carcinoma: a national populationbased study. Ann Surg Oncol 2008;15:1820-1827
-
(2008)
Ann Surg Oncol
, vol.15
, pp. 1820-1827
-
-
O'Connell, J.B.1
Maggard, M.A.2
Jr, M.J.3
-
7
-
-
43549116605
-
Systemic therapy for biliary tract cancers
-
Hezel AF, Zhu AX. Systemic therapy for biliary tract cancers. Oncologist 2008;13:415-423
-
(2008)
Oncologist
, vol.13
, pp. 415-423
-
-
Hezel, A.F.1
Zhu, A.X.2
-
8
-
-
8244254377
-
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized triaL
-
Burris HA III, Moore MJ, Andersen J, et aL Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized triaL J Clin Oncol 1997;15:2403-2413
-
(1997)
J Clin Oncol
, vol.15
, pp. 2403-2413
-
-
Iii, B.H.A.1
Moore, M.J.2
Andersen, J.3
-
9
-
-
33947387077
-
Chemotherapy in advanced biliary tract carcinoma: A pooled analysis of clinical trials
-
Eckel F, Schmid RM. Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials. Br J Cancer 2007; 96:896-902.
-
(2007)
Br J Cancer
, vol.96
, pp. 896-902
-
-
Eckel, F.1
Schmid, R.M.2
-
10
-
-
68749119637
-
Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: A multicentre randomised phase II study -the UK ABC-01 Study
-
Valle JW, Wasan H, Johnson P, et al. Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study -the UK ABC-01 Study. Br J Cancer 2009;101:621-627
-
(2009)
Br J Cancer
, vol.101
, pp. 621-627
-
-
Valle, J.W.1
Wasan, H.2
Johnson, P.3
-
11
-
-
77950822827
-
Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer
-
Valle J, Wasan H, Palmer DH, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 2010; 362:1273-1281
-
(2010)
N Engl J Med
, vol.362
, pp. 1273-1281
-
-
Valle, J.1
Wasan, H.2
Palmer, D.H.3
-
12
-
-
45749089796
-
Metastatic pancreatic cancer 2008: Is the glass less empty?
-
Nieto J, Grossbard ML, Kozuch P. Metastatic pancreatic cancer 2008: is the glass less empty? Oncologist 2008;13:562-576
-
(2008)
Oncologist
, Issue.13
, pp. 562-576
-
-
Nieto, J.1
Grossbard, M.L.2
Kozuch, P.3
-
13
-
-
38949111031
-
A review of phase 2-3 clinical trial designs
-
Thall PF. A review of phase 2-3 clinical trial designs. Lifetime Data Anal 2008;14:37-53.
-
(2008)
Lifetime Data Anal
, vol.14
, pp. 37-53
-
-
Thall, P.F.1
-
14
-
-
27244436755
-
Design issues of randomized phase II trials and a proposal for phase II screening trials
-
Rubinstein LV, Kom EL, Freidlin B, Hunsberger S, Ivy SP, Smith MA. Design issues of randomized phase II trials and a proposal for phase II screening trials. J Clin Oncol 2005;23:7199-7206
-
(2005)
J Clin Oncol
, vol.23
, pp. 7199-7206
-
-
Rubinstein, L.V.1
Kom, E.L.2
Freidlin, B.3
Hunsberger, S.4
Ivy, S.P.5
Ma, S.6
|